The first-in-human theranostic application of FAPI was the administration of Y-90-FAPI-04 in a female patient with metastasized breast cancer after a preceding diagnostic FAP-PET, showing a substantial intratumoral uptake27. The gene discussed is FAP; the disease is breast carcinoma.